Cargando…
Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, neurodegenerative disorder with a strong genetic component that acts in a complex interaction with environmental factors for disease development. CD4(+) T cells are pivotal players in MS pathogenesis, where peripherally activated T cells migrate...
Autores principales: | Cappelletti, Chiara, Eriksson, Anna, Brorson, Ina Skaara, Leikfoss, Ingvild S., Kråbøl, Oda, Høgestøl, Einar August, Vitelli, Valeria, Mjaavatten, Olav, Harbo, Hanne F., Berven, Frode, Bos, Steffan D., Berge, Tone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254507/ https://www.ncbi.nlm.nih.gov/pubmed/35790914 http://dx.doi.org/10.1186/s12014-022-09361-1 |
Ejemplares similares
-
Quantitative proteomic analyses of CD4(+) and CD8(+) T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls
por: Berge, Tone, et al.
Publicado: (2019) -
No differential gene expression for CD4(+) T cells of MS patients and healthy controls
por: Brorson, Ina S, et al.
Publicado: (2019) -
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells
por: Leikfoss, Ingvild S., et al.
Publicado: (2015) -
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A
por: Berge, Tone, et al.
Publicado: (2013) -
CD8(+) T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls
por: Brorson, IS, et al.
Publicado: (2020)